Unboxing Boxed Warnings and Risk Assessment for IG Products
FDA-mandated boxed warnings highlighting potential risks and clinicians performing comprehensive risk evaluations can help prevent the infrequent adverse drug reactions with IG products.
Using Synthetic Biology to Create Therapeutic Solutions
This revolutionary technology shows promise for addressing a myriad of challenges in medicine, but ethical dilemmas remain.
SARS-CoV-2 and COVID-19: Plasma Supply and IG Replacement Therapy to Protect Immunodeficient Patients
Can anti-SARS-CoV-2 antibodies in the plasma supply protect against COVID infection in
immunodeficient patients? Research suggests otherwise.
Plasma’s Pivotal Role in Cancer Therapy
Known as liquid gold, human plasma is proving to be a valuable ally in the fight against cancer.
Myths & Facts: Heart Disease (2026)
Heart disease is the leading cause of death in the U.S., so understanding its causes, diagnosis and treatment is imperative.
Complement Inhibitors as Therapeutic Agents for Autoimmune Disease
While still in their early stages of research, FDA has approved more than a dozen complement inhibitors to treat various conditions, and there is hope that more will be on the horizon to treat others.
Virtual Hospitals: A New Era of Care
Virtual hospitals bring hospital-level care directly to patients’ homes, representing a transformative step in healthcare delivery.
Update on Premenstrual Dysphoric Disorder (PMDD)
This severe form of PMS is characterized by significant mood and physical symptoms, and is now recognized and listed as a mental disorder that can be treated and even cured.
Myths & Facts: Prostate Cancer
Debunking the myths surrounding this second-deadliest cancer among men will help to convince them of the importance of getting screened since an early diagnosis has a 98 percent survival rate.
Dermatological Issues and Mental Health: Examining the Connections
Acne and rosacea can cause patients to withdraw from life, but medicine and psychological help can give patients their lives back.